CClinicalTrials.gg
CompletedNCT04356859ABRUPT2Updated May 20, 2026

The Acute Burn ResUscitation Multicenter Prospective Trial

An interventional study of Albumin Human in Burn Injury, sponsored by American Burn Association. Completed at 26 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-20.

Sponsored by American Burn Association · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
101
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid strategy (LR alone), in adults with an acute burn involving at least 25% of their total body surface area.

Read the detailed description

Enrolled subjects will be randomly assigned to either the Colloid Group or the Crystalloid Group. Randomization will be based on an intent-to-treat basis. In order to ensure that the two groups have comparable injury severity at baseline, randomization will be block- stratified based on age (18-50 and > 50 years), burn size (25-50% and > 50% TBSA), and presence of inhalation injury confirmed by bronchoscopy (present or absent). In the Colloid Group resuscitation starts with LR and then 5% albumin will be introduced between 8 and 12 hours post burn in a ratio of 1/3 albumin to 2/3 LR. In the Crystalloid Group resuscitation is with LR only. Each group will have their study fluid maintained for the 1st 48 hours post burn and study fluids in each group will be identically titrated to the urinary output.

02

Conditions studied

  • Burn Injury

Browse trials for

Keywords

  • Resuscitation
03

In context

Burns

719 studies on the registry are indexed under Burns; 145 are open to participants now.

This study's enrollment of 101 is above the median of 40 across 524 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

American Burn Association is the lead sponsor of 9 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 18 years
  • Total burn size (second and third degree) is ≥ 25% of the TBSA
  • Burn center admission within 12 hours of injury.
  • There is a plan for formal fluid resuscitation.

Exclusion criteria

Exclusion Criteria:

  • Significant associated trauma
  • High voltage (≥ 1000 volts) electrical burns
  • Burn wound excision surgery within 48 hours from injury
  • Fresh frozen plasma (FFP) given at any time ≤ 48 hours from injury
  • Hypertonic saline (HTS) given at any time ≤ 48 hours from injury
  • Hydroxyethyl starch (HES) given at any time ≤ 48 hours from injury
  • High dose Vitamin C infusion given at any time ≤ 48 hours from injury
  • Administration of human albumin prior to randomization
  • Palliative comfort measures are instituted ≤ 48 hours from injury
  • Pregnancy
  • Pre-injury chronic renal insufficiency equal to or greater than stage 3
  • Pre-injury chronic hepatic disease (Child-Pugh B or C)
  • Pre-injury left ventricular (LV) dysfunction (echocardiography LV grade II-IV or ejection fraction ≤ 35%)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
101 participants (actual)

Study arms

  • No intervention
    Crystalloid

    Subjects in the crystalloid group will receive fluid resuscitation with Lactated Ringer's titrated each hour to achieve a urine output of 0.5-1mL/kg predicted body weight.

  • Active comparator
    Colloid

    Subjects in the colloid group will receive fluid resuscitation with Lactated Ringer's and 5% human albumin solution introduced no earlier than 8 hours post burn and no later than 12 hours post burn in a ratio by volume of 1/3 albumin to 2/3 Lactated Ringer's, and titrated each hour to achieve a urine output of 0.5-1mL/kg (milliliter/kilogram) predicted body weight.

    Drug: Albumin Human

Interventions

  • DrugAlbumin Human

    Addition of albumin during acute resuscitation following burn injury

    Also known as: albumin

06

What researchers measure

Primary outcomes

  1. Volume of fluid received during resuscitation for burn injury

    Total fluid resuscitation volume at 24 hours post burn in mL/kg/% TBSA burn

    Time frame: 24 hours post burn injury

Secondary outcomes

  1. Volume of fluid received during resuscitation for burn injury

    Total resuscitation volume at 48 hours in mL/kg/%TBSA burn.

    Time frame: 48 hours post burn injury

  2. Urine output during resuscitation for burn injury

    Mean hourly urine output during resuscitation for burn injury

    Time frame: 24 and 48 hours post burn injury

  3. Number of crossovers

    Number of crossovers between study arms during resuscitation for burn injury

    Time frame: 48 hours post burn injury

  4. Peak lactate and delta lactate

    peak lactate level and delta lactate (peak lactate minus admission lactate)

    Time frame: 48 hours post burn injury

  5. Peak intra-abdominal pressure (IAP) and delta IAP

    Peak intra-abdominal pressure (IAP) and delta IAP (peak IAP minus admission IAP)

    Time frame: 48 hours post burn injury

  6. Occurrence of Abdominal compartment syndrome

    Abdominal compartment syndrome during resuscitation for burn injury

    Time frame: 48 hours post burn injury

  7. Occurrence of Limb or abdominal fasciotomy

    Limb or abdominal fasciotomy during resuscitation for burn injury

    Time frame: 48 hours post burn injury

  8. Sequential Organ Failure Assessment (SOFA) score

    Assessment of organ function or failure by Sequential Organ Failure Assessment (SOFA)score, with the higher score(s) indicating organ failure

    Time frame: 48, 72, and 96 hours post burn injury

  9. Acute kidney injury (AKI)

    Diagnosis of AKI

    Time frame: 96 hours post burn injury

  10. Duration of intubation/mechanical ventilation

    Duration of intubation/mechanical ventilation

    Time frame: 96 hours post burn injury

  11. PaO2/FiO2 ratios

    PaO2(partial pressure of oxygen)/FiO2(fraction of inspired oxygen inspired oxygen) ratios

    Time frame: 24, 48, 72, and 96 hours post burn injury

  12. Time to wound healing

    Time to wound healing defined as 7 days post last grafting surgery

    Time frame: 7 days post last surgery for grafting of burn injury

  13. Survival

    28 day survival and hospital stay survival

    Time frame: 28 days post injury and hospital discharge

07

Study locations

26 sites
  • Arizona Burn Center Valleywise Health
    Phoenix, Arizona 85008, United States
  • University of California Davis, Regional Burn Center
    Sacramento, California 95817, United States
  • Torrance Memorial
    Torrance, California 90505, United States
  • University of Florida Health
    Gainesville, Florida 32608, United States
  • University of Miami Health System
    Miami, Florida 33136, United States
  • University of South Florida
    Tampa, Florida 33606, United States
  • Loyola Medicine
    Maywood, Illinois 60153, United States
  • University of Iowa Healthcare
    Iowa City, Iowa 52242, United States
  • University of Kansas Health System
    Kansas City, Kansas 66160, United States
  • Ascension Via Christi St. Francis
    Wichita, Kansas 67214, United States
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
  • Hennepin Healthcare
    Minneapolis, Minnesota 55404, United States
  • Cooperman Barnabas Medical Center
    Livingston, New Jersey 07039, United States
  • Erie County Medical Center
    Buffalo, New York 14215, United States
  • Westchester Medical Center Health Network
    Valhalla, New York 10595, United States
  • Atrium Health Wake Forest Baptist Medical Center
    Winston-Salem, North Carolina 27157, United States
  • University of Cincinnati College of Medicine
    Cincinnati, Ohio 45267, United States
  • Metrohealth Medical Center
    Cleveland, Ohio 44109, United States
  • Legacy Health
    Portland, Oregon 97227, United States
  • West Penn Hospital
    Pittsburgh, Pennsylvania 15224, United States
  • The University of Tennessee Health Science Center
    Memphis, Tennessee 38163, United States
  • University of Utah Health
    Salt Lake City, Utah 84132, United States
  • Regional Burn Center at Harborview
    Seattle, Washington 98014, United States
  • University of Wisconsin Health
    Madison, Wisconsin 53792, United States
  • University of Alberta
    Edmonton, Alberta AB T6G 1Z1, Canada
  • Sunnybrook Health Sciences Centre
    Toronto, Ontario M4N3M5, Canada
08

References and documents

Publications

  • Pruitt BA Jr. Protection from excessive resuscitation: "pushing the pendulum back". J Trauma. 2000 Sep;49(3):567-8. doi: 10.1097/00005373-200009000-00030. No abstract available. PubMed 11003341 ↗
  • Zak AL, Harrington DT, Barillo DJ, Lawlor DF, Shirani KZ, Goodwin CW. Acute respiratory failure that complicates the resuscitation of pediatric patients with scald injuries. J Burn Care Rehabil. 1999 Sep-Oct;20(5):391-9. doi: 10.1097/00004630-199909000-00011. PubMed 10501327 ↗
  • Hobson KG, Young KM, Ciraulo A, Palmieri TL, Greenhalgh DG. Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma. 2002 Dec;53(6):1129-33; discussion 1133-4. doi: 10.1097/00005373-200212000-00016. PubMed 12478039 ↗
  • Klein MB, Hayden D, Elson C, Nathens AB, Gamelli RL, Gibran NS, Herndon DN, Arnoldo B, Silver G, Schoenfeld D, Tompkins RG. The association between fluid administration and outcome following major burn: a multicenter study. Ann Surg. 2007 Apr;245(4):622-8. doi: 10.1097/01.sla.0000252572.50684.49. PubMed 17414612 ↗
  • Recinos PR, Hartford CA, Ziffren SE. Fluid resuscitation of burn patients comparing a crystalloid with a colloid containing solution: a prospective study. J Iowa Med Soc. 1975 Oct;65(10):426-32. No abstract available. PubMed 1194720 ↗
  • Goodwin CW, Dorethy J, Lam V, Pruitt BA Jr. Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Ann Surg. 1983 May;197(5):520-31. doi: 10.1097/00000658-198305000-00004. PubMed 6342554 ↗
  • Cooper AB, Cohn SM, Zhang HS, Hanna K, Stewart TE, Slutsky AS; ALBUR Investigators. Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion. 2006 Jan;46(1):80-9. doi: 10.1111/j.1537-2995.2005.00667.x. PubMed 16398734 ↗
  • O'Mara MS, Slater H, Goldfarb IW, Caushaj PF. A prospective, randomized evaluation of intra-abdominal pressures with crystalloid and colloid resuscitation in burn patients. J Trauma. 2005 May;58(5):1011-8. doi: 10.1097/01.ta.0000162732.39083.15. PubMed 15920417 ↗
  • Muller Dittrich MH, Brunow de Carvalho W, Lopes Lavado E. Evaluation of the "Early" Use of Albumin in Children with Extensive Burns: A Randomized Controlled Trial. Pediatr Crit Care Med. 2016 Jun;17(6):e280-6. doi: 10.1097/PCC.0000000000000728. PubMed 27077832 ↗
  • Cartotto R, Callum J. A review of the use of human albumin in burn patients. J Burn Care Res. 2012 Nov-Dec;33(6):702-17. doi: 10.1097/BCR.0b013e31825b1cf6. PubMed 23143614 ↗
  • Baxter CR, Shires T. Physiological response to crystalloid resuscitation of severe burns. Ann N Y Acad Sci. 1968 Aug 14;150(3):874-94. doi: 10.1111/j.1749-6632.1968.tb14738.x. No abstract available. PubMed 4973463 ↗
  • Pruitt BA Jr. Fluid and electrolyte replacement in the burned patient. Surg Clin North Am. 1978 Dec;58(6):1291-1312. doi: 10.1016/s0039-6109(16)41692-0. No abstract available. PubMed 734610 ↗
  • Pruitt BA Jr. The burn patient: II. Later care and complications of thermal injury. Curr Probl Surg. 1979 May;16(5):1-95. doi: 10.1016/s0011-3840(79)80009-x. PubMed 376227 ↗
  • Cartotto RC, Innes M, Musgrave MA, Gomez M, Cooper AB. How well does the Parkland formula estimate actual fluid resuscitation volumes? J Burn Care Rehabil. 2002 Jul-Aug;23(4):258-65. doi: 10.1097/00004630-200207000-00006. PubMed 12142578 ↗
  • Cartotto R, Zhou A. Fluid creep: the pendulum hasn't swung back yet! J Burn Care Res. 2010 Jul-Aug;31(4):551-8. doi: 10.1097/BCR.0b013e3181e4d732. PubMed 20616649 ↗
  • Engrav LH, Colescott PL, Kemalyan N, Heimbach DM, Gibran NS, Solem LD, Dimick AR, Gamelli RL, Lentz CW. A biopsy of the use of the Baxter formula to resuscitate burns or do we do it like Charlie did it? J Burn Care Rehabil. 2000 Mar-Apr;21(2):91-5. doi: 10.1097/00004630-200021020-00002. PubMed 10752739 ↗
  • Cancio LC, Chavez S, Alvarado-Ortega M, Barillo DJ, Walker SC, McManus AT, Goodwin CW. Predicting increased fluid requirements during the resuscitation of thermally injured patients. J Trauma. 2004 Feb;56(2):404-13; discussion 413-4. doi: 10.1097/01.TA.0000075341.43956.E4. PubMed 14960986 ↗
  • Saffle JI. The phenomenon of "fluid creep" in acute burn resuscitation. J Burn Care Res. 2007 May-Jun;28(3):382-95. doi: 10.1097/BCR.0B013E318053D3A1. PubMed 17438489 ↗
  • Jelenko C 3rd, Williams JB, Wheeler ML, Callaway BD, Fackler VK, Albers CA, Barger AA. Studies in shock and resuscitation, I: use of a hypertonic, albumin-containing, fluid demand regimen (HALFD) in resuscitation. Crit Care Med. 1979 Apr;7(4):157-67. PubMed 446052 ↗
  • Lawrence A, Faraklas I, Watkins H, Allen A, Cochran A, Morris S, Saffle J. Colloid administration normalizes resuscitation ratio and ameliorates "fluid creep". J Burn Care Res. 2010 Jan-Feb;31(1):40-7. doi: 10.1097/BCR.0b013e3181cb8c72. PubMed 20061836 ↗
  • Faraklas I, Lam U, Cochran A, Stoddard G, Saffle J. Colloid normalizes resuscitation ratio in pediatric burns. J Burn Care Res. 2011 Jan-Feb;32(1):91-7. doi: 10.1097/BCR.0b013e318204b379. PubMed 21131844 ↗
  • Mehrkens HH, Ahnefeld FW. Volume and fluid replacement in the early post burn period: an animal experimental study. Burns 1979;5:113-15
  • Asch MJ, Feldman RJ, Walker HL, Foley FD, Popp RL, Mason AD Jr, Pruitt BA Jr. Systemic and pulmonary hemodynamic changes accompanying thermal injury. Ann Surg. 1973 Aug;178(2):218-21. doi: 10.1097/00000658-197308000-00020. No abstract available. PubMed 4723430 ↗
  • Demling RH, Kramer G, Harms B. Role of thermal injury-induced hypoproteinemia on fluid flux and protein permeability in burned and nonburned tissue. Surgery. 1984 Feb;95(2):136-44. PubMed 6695330 ↗
  • Demling RH, Kramer GC, Gunther R, Nerlich M. Effect of nonprotein colloid on postburn edema formation in soft tissues and lung. Surgery. 1984 May;95(5):593-602. PubMed 6200946 ↗
  • Onarheim H, Reed RK. Thermal skin injury: effect of fluid therapy on the transcapillary colloid osmotic gradient. J Surg Res. 1991 Mar;50(3):272-8. doi: 10.1016/0022-4804(91)90190-w. PubMed 1999916 ↗
  • Moncrief JA. Effect of various fluid regimens and pharmacologic agents on the circulatory hemodynamics of the immediate postburn period. Ann Surg. 1966 Oct;164(4):723-52. doi: 10.1097/00000658-196610000-00017. No abstract available. PubMed 5924792 ↗
  • Park SH, Hemmila MR, Wahl WL. Early albumin use improves mortality in difficult to resuscitate burn patients. J Trauma Acute Care Surg. 2012 Nov;73(5):1294-7. doi: 10.1097/TA.0b013e31827019b1. PubMed 23117385 ↗
  • Greenhalgh DG. Current Thoughts on Burn Resuscitation. Adv Surg. 2024 Sep;58(1):1-17. doi: 10.1016/j.yasu.2024.04.001. Epub 2024 May 8. PubMed 39089770 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04356859
Lead sponsor
American Burn Association
Collaborators
United States Department of Defense
Responsible party
Sponsor
First posted
Apr 22, 2020
Start date
Apr 22, 2021
Primary completion
Sep 29, 2025
Completion
Sep 29, 2025
Last update
May 20, 2026

Study contacts

David G Greenhalgh, MD
principal investigator · UC Davis Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion